HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

L Neckers Selected Research

acetyl-leucinal-nor-leucinal

10/2001Effect of the proteasome inhibitor ALLnL on cisplatin sensitivity in human ovarian tumor cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


L Neckers Research Topics

Disease

6Neoplasms (Cancer)
04/2008 - 04/2000
4Carcinoma (Carcinomatosis)
10/2001 - 02/2000
2Kidney Neoplasms (Kidney Cancer)
02/2007 - 01/2006
2Ovarian Neoplasms (Ovarian Cancer)
10/2001 - 01/2001
2Carcinogenesis
02/2001 - 06/2000
1Neoplasm Metastasis (Metastasis)
04/2008
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2007
1Leukemia
12/2007
1Hereditary leiomyomatosis and renal cell cancer
01/2006
1Prion Diseases (Transmissible Spongiform Encephalopathies)
09/2003
1Neurodegenerative Diseases (Neurodegenerative Disease)
09/2003
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
02/2001
1Lung Neoplasms (Lung Cancer)
02/2001
1Hypoxia (Hypoxemia)
06/2000
1Melanoma (Melanoma, Malignant)
02/2000
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
02/2000
1Adenocarcinoma
01/2000

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
04/2008 - 02/2000
3Proteasome Endopeptidase Complex (Proteasome)IBA
10/2001 - 02/2000
3Cisplatin (Platino)FDA LinkGeneric
10/2001 - 11/2000
2Molecular Chaperones (Chaperone, Molecular)IBA
04/2008 - 01/2006
2Heat-Shock Proteins (Heat-Shock Protein)IBA
04/2008 - 01/2006
2Tyrosine (L-Tyrosine)FDA Link
12/2007 - 02/2001
2beta CateninIBA
12/2007 - 02/2000
2Fumarate Hydratase (Fumarase)IBA
02/2007 - 01/2006
2Proteasome InhibitorsIBA
10/2001 - 11/2000
2Phosphotransferases (Kinase)IBA
02/2001 - 01/2000
2Conditioned Culture MediaIBA
02/2001 - 06/2000
2Messenger RNA (mRNA)IBA
02/2001 - 06/2000
1DMAG-N-oxideIBA
04/2008
1IntegrinsIBA
04/2008
1Prion ProteinsIBA
09/2003
1PlatinumIBA
10/2001
1acetyl-leucinal-nor-leucinalIBA
10/2001
1ErbB Receptors (EGF Receptor)IBA
02/2001
1LigandsIBA
02/2001
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2001
1Adenylyl Cyclases (Adenylyl Cyclase)IBA
02/2001
1Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
02/2001
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2001
1Protein Isoforms (Isoforms)IBA
02/2001
1Dinoprostone (PGE2)FDA Link
02/2001
1lactacystinIBA
01/2001
1DNA AdductsIBA
11/2000
1Antineoplastic Agents (Antineoplastics)IBA
11/2000
1ChromatinIBA
11/2000
1Histones (Histone)IBA
11/2000
1cisplatin-DNA adductIBA
11/2000
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
06/2000
1AdrenomedullinIBA
06/2000
1Mesylates (Mesylate)IBA
06/2000
1Deferoxamine (Desferal)FDA LinkGeneric
06/2000
1Oxygen (Dioxygen)IBA
06/2000
1LuciferasesIBA
06/2000
1MitogensIBA
06/2000
1NF-kappa B (NF-kB)IBA
04/2000
1Pharmaceutical PreparationsIBA
04/2000
1Glycogen Synthase (Synthase I)IBA
02/2000
1Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
02/2000
1Detergents (Detergent)IBA
02/2000

Therapy/Procedure

1Drug Therapy (Chemotherapy)
01/2000